NCT03836391 (Nudge) is a NA clinical trial of Nudge in Overweight and Obesity, sponsored by University of North Carolina, Chapel Hill.

Who is sponsoring NCT03836391?

NCT03836391 is sponsored by University of North Carolina, Chapel Hill.

What drugs are being tested in NCT03836391?

Interventions in NCT03836391: Nudge.

What condition does NCT03836391 study?

NCT03836391 studies Overweight and Obesity, Overweight, Obesity.

Is NCT03836391 still recruiting?

NCT03836391 is currently completed. Last updated 13 November 2019.

Last reviewed 2019-11-13 · How we verify

NCT03836391: Nudge

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Precision Public Health: Enhancing Connections to Develop Just-in-Time Adaptive Intervention Strategies

Completed NA Last updated 13 November 2019

What this trial tests

NA trial testing Nudge in Overweight and Obesity in 53 participants. Completed in 16 September 2019.

Timeline

12 February 2019

Primary endpoint
16 September 2019

16 September 2019

Quick facts

Lead sponsor	University of North Carolina, Chapel Hill
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	53
Start date	12 February 2019
Primary completion	16 September 2019
Estimated completion	16 September 2019
Sites	1 location across United States

Drugs / interventions tested

Nudge

Conditions studied

Overweight and Obesity — all drugs for Overweight and Obesity →
Overweight — all drugs for Overweight →
Obesity — all drugs for Obesity →

Sponsor

University of North Carolina, Chapel Hill

Who can join

Adults 18 to 35, any sex, with Overweight and Obesity or Overweight. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this pilot study is to examine the effects of different types of just-in-time intervention messages on daily meeting dietary, activity, and weighing goals in a sample of young adults participating in a mobile-based weight loss program.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Outcomes of a pilot microrandomized trial of just-in-time adaptive intervention messages nudging weight-related behaviors in young adults.
Valle CG, Nezami BT, O'Shea NG, Hatley KE, et al · · 2025 · PMID 40631347 · DOI 10.1177/20552076251353267
Fluctuations in mHealth engagement following receipt of goal-discrepant feedback messages.
Hurley L, O'Shea NG, Nezami BT, Valle CG, et al · · 2025 · PMID 39801582 · DOI 10.1177/20552076241312569

Verify or expand the search:

Other trials of Nudge

Trials testing the same drug.

NCT07078409 — Clinician Nudge to Referral of Adnexal Masses to Gynecologic Oncology · NA · enrolling by invitation
NCT06451263 — Nudge to Gynecologic Oncology · NA · active not recruiting
NCT05613751 — Enhancing Protection Against Influenza and COVID-19 for Pregnant Women and Medically at Risk Children · NA · unknown
NCT05250778 — Nudges on Hospitalist Behavior and Patient Satisfaction · NA · completed
NCT04844021 — Adolescent and Child Suicide Prevention in Routine Clinical Encounters · NA · completed

Other recruiting trials for Overweight and Obesity

Currently open trials in the same condition.

NCT06282952 — Health Outcomes in C-Section Infants With Fecal Microbiota Transplantation · NA · recruiting
NCT07406191 — WB-EMS Effects on Cardiometabolic Risk Factors · NA · recruiting
NCT07230496 — A Study to Investigate Safety, Tolerability and Pharmacokinetics of LAE103 or LAE103 in Combination With LAE102 in Healt · Phase 1 · recruiting
NCT07313761 — A Trial to Compare the Extent to Which Maridebart Cafraglutide (AMG 133) is Made Available in the Body When Administered · Phase 1 · active not recruiting
NCT07165431 — Effect of a Postbiotic Supplementation in Overweight and Obese Subjects: A Randomized Controlled Trial (PARABIOTICS-2). · NA · recruiting

Other University of North Carolina, Chapel Hill trials

Trials by the same sponsor.

NCT06841913 — Woodsmoke Exposure, Influenza Infection, and Nasal Immunity · Phase 4 · suspended
NCT07383428 — The INICIO-Guatemala Study · NA · not yet recruiting
NCT07528443 — Ultraprocessed Foods in Colombia · NA · not yet recruiting
NCT07507370 — CARED : A Novel Rapid Treatment Paradigm for Depression · NA · not yet recruiting
NCT07534254 — Piloting a Generative Artificial Intelligence Chatbot in a Mobile Weight Loss Program · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03836391 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of North Carolina, Chapel Hill
Last refreshed: 13 November 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03836391.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing